04:51 PM EDT, 04/01/2024 (MT Newswires) -- Integra LifeSciences Holdings ( IART ) said Monday it has completed its acquisition of Acclarent from Johnson & Johnson ( JNJ ) MedTech company to enhance its position in the ear, nose and throat treatment market.
In December, Integra agreed to acquire Acclarent for $275 million in cash.
Price: 34.8, Change: +0.08, Percent Change: +0.23